Abstract Body

Both daily and event-driven (i.e. before and after sex) pre-exposure prophylaxis (PrEP) regimens are effective against HIV acquisition. However, information about adherence to event-driven PrEP is scarce and predominantly based on self-reported data collected at 3-month intervals. We used a mobile-based diary application and intracellular tenofovir diphosphate (TFV-DP) levels to assess adherence among event-driven PrEP users participating in the Amsterdam PrEP demonstration project (AMPrEP) in the Netherlands.

Participants could choose and switch between daily and event-driven PrEP regimens. Participants used a mobile application to record their sexual behaviour and pill use on a daily basis. We studied adherence by assessing (1) the number of condomless anal sex (CAS) acts covered by PrEP using data collected by the mobile application and (2) the correlation between TFV-DP concentrations (measured in dried blood spot (DBS) samples taken at the 3, 6 or 9, and 12 and 24 month visits; lower level of detection 12.5 fmol/punch) and CAS, and between TFV-DP concentrations and self-reported pill use. Good adherence was defined as at least one tablet before a CAS act and one tablet within 48 hours of that CAS act.

Between September 2015 and February 2019, 139 of 376 (37.0%) AMPrEP participants used event-driven PrEP for at least 3 months. In this period, a total of 6,583 CAS acts were reported in the mobile application during event-driven PrEP use, of which 5,518 (83.8%) were covered by good PrEP adherence. Good PrEP adherence was more common around CAS acts with known (93.0%) and unknown (90.4%) casual partners, than with a steady partner (56.2%; p<0.001). Median TFV-DP concentration was 528 fmol/punch (IQR 232-900; levels ≥700 fmol/punch are correlated with use of at least 4 pills per week in the preceding 6 weeks) and higher TFV-DP concentration was associated with the number of self-reported CAS acts (β=0.15, 95% CI 0.11-0.19) and with the number of pills taken (β=0.08, 95% CI 0.06-0.09) in the 6 weeks before the DBS.

In our PrEP demonstration study, the majority of reported CAS acts were covered by PrEP. Self-reported adherence to event-driven PrEP was very high for CAS acts with unknown and known casual sex partners, suggesting that MSM use event-driven PrEP when they are most at risk for HIV. Observed TDF levels in event-driven PrEP users are lower than those reported from studies among daily users.